[1]
R. S. Vastyanov and Y. S. Strelnikova, “Levetiracetam antiepilepticefficacy increasing using recombinant inter leukin-1 receptors antagonist in conditions of experimental chronic convulsive syndrome”, Biomed. and Biosoc. Anthrop., no. 26, pp. 65-68, Mar. 2017.